A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients

被引：0

作者：

M Gentile

T D Shanafelt

G Cutrona

S Molica

G Tripepi

I Alvarez

F R Mauro

N Di Renzo

F Di Raimondo

I Vincelli

K Todoerti

S Matis

C Musolino

S Fabris

E Vigna

L Levato

S Zupo

F Angrilli

U Consoli

G Festini

G Longo

A Cortelezzi

A Arcari

M Federico

D Mannina

A G Recchia

A Neri

N E Kay

M Ferrarini

F Morabito

机构：

[1] Hematology Unit,Department of Onco

[2] A.O. of Cosenza,hematology

[3] Mayo Clinic,Division of Hematology, Department of Internal Medicine

[4] SS Molecular Diagnostics IRCCS S. Martino-IST,Dipartimento di diagnostica della patologia e delle cure ad alta complessità tecnologica

[5] Pugliese-Ciaccio Hospital,Department of Oncology and Haematology

[6] Consiglio Nazionale delle Ricerche,Division of Haematology, Dipartimento Oncologico e Tecnologie Avanzate

[7] Istituto di Fisiologia Clinica,Divisione di Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia

[8] Arcispedale S. Maria Nuova/IRCCS,Division of Haematology, Department of Biomedical Sciences

[9] Università La Sapienza,Dipartimento di Onco

[10] Hematology Unit,Ematologia

[11] Ospedale Vito Fazzi,Department of Clinical Sciences and Community Health

[12] University of Catania and Ferrarotto Hospital,Department of Hematology

[13] Hematology Unit,Dipartimento ad Attività Integrata Oncologia

[14] A.O. of Reggio Calabria,Dipartimento di Oncologia

[15] Reggio Calabria,Dipartimento di Oncologia ed Ematologia, Department of Onco

[16] Laboratory of Preclinical and Translational Research,Hematology

[17] IRCCS,Department of Onco

[18] Referral Cancer Center of Basilicata,hematology

[19] Direzione Scientifica IRCCS,Divisione di Ematologia

[20] San Martino IST,undefined

[21] Division of Haematology,undefined

[22] Dipartimento di Medicina Interna,undefined

[23] University of Messina,undefined

[24] University of Milano and Hematology CTMO,undefined

[25] Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico,undefined

[26] Ospedale Santo Spirito,undefined

[27] U.O.S. di Emato-Oncologia,undefined

[28] Ospedale Garibaldi-Nesima,undefined

[29] Centro di Riferimento Ematologico-Seconda Medicina,undefined

[30] Azienda Ospedaliero-Universitaria,undefined

[31] Ospedali Riuniti,undefined

[32] Unità di Ematologia,undefined

[33] Ospedale San Vincenzo,undefined

[34] Hematology Unit,undefined

[35] Guglielmo da Saliceto Hospital,undefined

[36] Università di Modena Centro Oncologico Modenese,undefined

[37] Ospedale Papardo,undefined

[38] Biotechnology Research Unit,undefined

[39] Azienda Sanitaria Provinciale di Cosenza,undefined

来源：

Leukemia | 2016年 / 30卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1440 / 1443

页数：3

共 50 条

[31] Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib
Sigmund, Audrey M.
Huang, Ying
Ruppert, Amy S.
Maddocks, Kami
Rogers, Kerry A.
Jaglowski, Samantha
Bhat, Seema A.
Kittai, Adam S.
Grever, Michael R.
Byrd, John C.
Woyach, Jennifer A.
LEUKEMIA, 2022, 36 (08) : 2129 - 2131
[32] Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib
Audrey M. Sigmund
Ying Huang
Amy S. Ruppert
Kami Maddocks
Kerry A. Rogers
Samantha Jaglowski
Seema A. Bhat
Adam S. Kittai
Michael R. Grever
John C. Byrd
Jennifer A. Woyach
Leukemia, 2022, 36 : 2129 - 2131
[33] The Effect of Mind-Body Intervention on Lymphocyte Doubling Time and Treatment-Free Survival in Treatment-Naïve Chronic Lymphocytic Leukemia Patients
Shapira, Shirley
Hirschberger, Naama
Ofran, Yishai
Mizrahi, Barak
Mandel, Esti
Benjamini, Ohad
Rabinowicz, Noa
Zoref-Lorenz, Adi
ACTA HAEMATOLOGICA, 2024,
[34] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
Beauchemin, C.
Johnston, J.
Lapierre, M. E.
Aissa, F.
Lachaine, J.
VALUE IN HEALTH, 2012, 15 (07) : A414 - A415
[35] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
Beauchemin, C.
Johnston, J. B.
Lapierre, M.
Aissa, F.
Lachaine, J.
ANNALS OF ONCOLOGY, 2012, 23 : 350 - 350
[36] Prediagnostic Progression of Lymphocytosis in Chronic Lymphocytic Leukemia Is Predictive of Progression Free Survival As Early As Five Years Prior to Diagnosis
Andersen, Michael Asger
Grand, Mia Klinten
Siersma, Volkert
Olivarius, Niels
Andersen, Christen Lykkegaard
Niemann, Carsten Utoft
BLOOD, 2017, 130
[37] Association of HLA-G haplotype risk model with treatment free survival in chronic lymphocytic leukemia patients
Kapp, J.
Ochsenfarth, C.
Switala, M.
Frey, U.
Sellmann, L.
Duerig, J.
Horn, P.
Duehrsen, U.
Rebmann, V
Nueckel, H.
ONKOLOGIE, 2010, 33 : 45 - 45
[38] Association of HLA-G Haplotype Risk Model with Treatment Free Survival In Chronic Lymphocytic Leukemia Patients
Kapp, Johanna
Ochsenfarth, Crista
Switala, Magdalena
Frey, Ulrich
Sellmann, Ludger
Duerig, Jan
Horn, Peter A.
Duehrsen, Ulrich
Rebmann, Vera
Nuckel, Holger
BLOOD, 2010, 116 (21) : 1002 - 1003
[39] International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
Condoluci, Adalgisa
di Bergamo, Lodovico Terzi
Langerbeins, Petra
Hoechstetter, Manuela A.
Herling, Carmen D.
De Paoli, Lorenzo
Delgado, Julio
Rabe, Kari G.
Gentile, Massimo
Doubek, Michael
Mauro, Francesca R.
Chiodin, Giorgia
Mattsson, Mattias
Bahlo, Jasmin
Cutrona, Giovanna
Kotaskova, Jana
Deambrogi, Clara
Smedby, Karin E.
Spina, Valeria
Bruscaggin, Alessio
Wu, Wei
Moia, Riccardo
Bianchi, Elena
Gerber, Bernhard
Zucca, Emanuele
Gillessen, Silke
Ghielmini, Michele
Cavalli, Franco
Stussi, Georg
Hess, Mark A.
Baumann, Tycho S.
Neri, Antonino
Ferrarini, Manlio
Rosenquist, Richard
Forconi, Francesco
Foa, Robin
Pospisilova, Sarka
Morabito, Fortunato
Stilgenbauer, Stephan
Doehner, Hartmut
Parikh, Sameer A.
Wierda, William G.
Montserrat, Emili
Gaidano, Gianluca
Hallek, Michael
Rossi, Davide
BLOOD, 2020, 135 (21) : 1859 - 1869
[40] Complete Response Linked to Progression-Free Survival in Chronic Lymphocytic Leukemia
Schuyler, Devon
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 92 - 92

← 1 2 3 4 5 →